中國(guó)經(jīng)(jīng)濟(jì)網(wǎng)(wǎng)5月23日訊(記者 郭文培) 《中華人民共和國(guó)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》(以下簡(jiǎn)(jiǎn)稱(chēng)《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》)于5月20日起正式施行。作為我國(guó)第一部專(zhuān)門(mén)(mén)關(guān)(guān)于民營(yíng)(yíng)經(jīng)(jīng)濟(jì)發(fā)(fā)展的基礎(chǔ)性法律,《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》積極回應(yīng)了民營(yíng)(yíng)經(jīng)(jīng)濟(jì)發(fā)(fā)展中的重點(diǎn)(diǎn)關(guān)(guān)切。民營(yíng)(yíng)企業(yè)(yè)家們對(duì)該法律有哪些期待和感受?近日,作為全國(guó)人大代表、以嶺藥業(yè)(yè)股份有限公司董事長(zhǎng)(cháng)吳相君就此話(huà)題接受了中國(guó)經(jīng)(jīng)濟(jì)網(wǎng)(wǎng)專(zhuān)訪(fǎng)。
“《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》出臺(tái),是我國(guó)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)法治建設(shè)進(jìn)(jìn)程中的一件大事,也是民營(yíng)(yíng)經(jīng)(jīng)濟(jì)高質(zhì)(zhì)量發(fā)(fā)展的重大利好,我倍感振奮,深受鼓舞?!眳竅嗑f(shuō)(shuō),“《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》充分體現(xiàn)了黨和國(guó)家對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)的高度重視和堅(jiān)定支持,其中,我體會(huì)(huì )最深的當(dāng)數(shù)科技創(chuàng)(chuàng )新?!?/p>
吳相君介紹,民營(yíng)(yíng)經(jīng)(jīng)濟(jì)是科技創(chuàng)(chuàng )新的重要力量,集中了90%以上的國(guó)家高新技術(shù)(shù)企業(yè)(yè),貢獻(xiàn)了70%以上的技術(shù)(shù)創(chuàng)(chuàng )新成果?!啊睹駹I(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》把科技創(chuàng)(chuàng )新單獨(dú)設(shè)為一章,足見(jiàn)(jiàn)其重視程度。特別是明確提出,鼓勵(lì)、支持民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織在推動(dòng)(dòng)科技創(chuàng)(chuàng )新、培育新質(zhì)(zhì)生產(chǎn)(chǎn)力、建設(shè)現(xiàn)代化產(chǎn)(chǎn)業(yè)(yè)體系中積極發(fā)(fā)揮作用。支持民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織參與國(guó)家科技攻關(guān)(guān)項(xiàng)目,牽頭承擔(dān)國(guó)家重大技術(shù)(shù)攻關(guān)(guān)任務(wù)(wù),向民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織開(kāi)(kāi)放國(guó)家重大科研基礎(chǔ)設(shè)施。支持民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織加強(qiáng)新技術(shù)(shù)應(yīng)用,加強(qiáng)對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織及其經(jīng)(jīng)營(yíng)(yíng)者原始創(chuàng)(chuàng )新的保護(hù)。這充分體現(xiàn)對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)推動(dòng)(dòng)科技創(chuàng)(chuàng )新的重視支持,也釋放了用法治保障民營(yíng)(yíng)經(jīng)(jīng)濟(jì)創(chuàng)(chuàng )新發(fā)(fā)展的信號(hào)?!?/p>
在吳相君看來(lái)(lái),《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》進(jìn)(jìn)一步明確了民營(yíng)(yíng)經(jīng)(jīng)濟(jì)的法律地位,對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織及其經(jīng)(jīng)營(yíng)(yíng)者的人身權(quán)利、財(cái)產(chǎn)(chǎn)權(quán)利以及經(jīng)(jīng)營(yíng)(yíng)自主權(quán)等合法權(quán)益給予法律保護(hù),提出國(guó)家保障民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織依法平等使用資金、技術(shù)(shù)、人力資源、數(shù)據(jù)、土地及其他自然資源等各類(lèi)生產(chǎn)(chǎn)要素和公共服務(wù)(wù)資源,依法平等適用國(guó)家支持發(fā)(fā)展的政策。同時(shí)(shí),提出對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)組織在投資融資方面給予支持,進(jìn)(jìn)一步優(yōu)(yōu)化對(duì)民營(yíng)(yíng)經(jīng)(jīng)濟(jì)的服務(wù)(wù)保障,努力營(yíng)(yíng)造市場(chǎng)(chǎng)化、法治化、國(guó)際化一流營(yíng)(yíng)商環(huán)(huán)境。這讓民營(yíng)(yíng)企業(yè)(yè)吃下了創(chuàng)(chuàng )新驅(qū)動(dòng)(dòng)、高質(zhì)(zhì)量發(fā)(fā)展的法治“定心丸”,也有利于為民營(yíng)(yíng)企業(yè)(yè)創(chuàng)(chuàng )造良好的創(chuàng)(chuàng )新生態(tài)(tài)。
談及企業(yè)(yè)自身發(fā)(fā)展,吳相君表示,以嶺藥業(yè)(yè)已創(chuàng)(chuàng )辦30多年。一直以來(lái)(lái),公司堅(jiān)持走科技創(chuàng)(chuàng )新、成果轉(zhuǎn)化、產(chǎn)(chǎn)業(yè)(yè)發(fā)(fā)展之路,積極承擔(dān)國(guó)家973、863和國(guó)家重點(diǎn)(diǎn)研發(fā)(fā)計(jì)劃科研項(xiàng)目,形成一批科研成果,榮獲6項(xiàng)國(guó)家重大科技成果獎(jiǎng),研發(fā)(fā)生產(chǎn)(chǎn)15個(gè)(gè)創(chuàng)(chuàng )新中藥,覆蓋心腦血管、呼吸、內(nèi)分泌等八大疾病領(lǐng)(lǐng)域,產(chǎn)(chǎn)品被列入227項(xiàng)臨床診療指南和專(zhuān)家共識(shí)。下一步,以嶺藥業(yè)(yè)將以《民營(yíng)(yíng)經(jīng)(jīng)濟(jì)促進(jìn)(jìn)法》出臺(tái)為契機(jī),持續(xù)抓好科技創(chuàng)(chuàng )新和科研攻關(guān)(guān),研發(fā)(fā)生產(chǎn)(chǎn)更多適合中國(guó)人生命基因傳承和身體素質(zhì)(zhì)特點(diǎn)(diǎn)的“中國(guó)藥”,為中醫(yī)藥事業(yè)(yè)高質(zhì)(zhì)量發(fā)(fā)展和健康中國(guó)建設(shè)作出新的更大貢獻(xiàn)。